Molecular dynamics simulation results of Bamocaftor (Blue), Ivacaftor (Red) and Galicaftor (Green) with CFTR (Black). por Naisarg Patel (21772572)

Subjects:

Results of the MMPBSA analysis. por Naisarg Patel (21772572)

Subjects:

Results of Post-Simulation protonation analysis. por Naisarg Patel (21772572)

Subjects:

Table 1_Practitioners’ and researchers’ perspectives on treatment needs and service provision for online child sexual abuse.docx por Felipa Schmidt (17273704)

Data Sheet 2_Decades of failure to prevent harm to patients—where are we going wrong? A mixed methods study of the perspectives of health services staff across Australia and intern... por Mia Bierbaum (5899037)

Data Sheet 3_Decades of failure to prevent harm to patients—where are we going wrong? A mixed methods study of the perspectives of health services staff across Australia and intern... por Mia Bierbaum (5899037)

Data Sheet 1_Decades of failure to prevent harm to patients—where are we going wrong? A mixed methods study of the perspectives of health services staff across Australia and intern... por Mia Bierbaum (5899037)

Participant characteristics. por Zamzam I. A. Ali (21688437)

Subjects: “...acknowledging potential harms...”

Development of immune factors over visits in the persistent and resolved CMA group as (A) scores and (B) loadings. por Diana M. Hendrickx (1507435)

Development of immune factors over visits in the AAF and AAF-syn treatment group as (A) scores and (B) loadings. por Diana M. Hendrickx (1507435)

Results of comparing visits within allergy groups using linear mixed models and post hoc analysis. por Diana M. Hendrickx (1507435)

Results of comparing allergy groups within visits using linear mixed models and post hoc analysis. por Diana M. Hendrickx (1507435)

Development of immune factors over visits in the AAF-syn treatment group as (A) scores and (B) loadings when using the AAF treatment group as a reference. por Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using linear mixed models and post hoc analysis. por Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within allergy groups as determined by linear mixed models and post hoc analysis. por Diana M. Hendrickx (1507435)

Results of comparing visits within treatment groups using linear mixed models and post hoc analysis. por Diana M. Hendrickx (1507435)

Development of immune factors over visits in the persistent and resolved CMA group as (A) scores and (B) loadings when using the persistent CMA group as a reference. por Diana M. Hendrickx (1507435)

Proteins with at least one significant difference (adjusted p-value ≤ 0.05) between visits within treatment groups as determined by linear mixed models and post hoc analysis. por Diana M. Hendrickx (1507435)

KEGG pathways (with at least 4 measured proteins) that have at least one significant difference (adjusted p-value (q-value) ≤ 0.05) between treatment groups within visits as determ... por Diana M. Hendrickx (1507435)

Results of comparing treatment groups within visits using KEGG pathway enrichment in ConsensusPathDB. por Diana M. Hendrickx (1507435)